Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001615774-18-004019
Filing Date
2018-05-17
Accepted
2018-05-17 17:16:05
Documents
1
Period of Report
2018-05-15

Document Format Files

Seq Description Document Type Size
1 4 s110299_form4.html 4  
1 4 s110299_form4.xml 4 3907
  Complete submission text file 0001615774-18-004019.txt   5378
Mailing Address 61 MOULTON ST CAMBRIDGE MA 02138
Business Address
MISSLING CHRISTOPHER U (Reporting) CIK: 0001196573 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37606 | Film No.: 18844046

Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Issuer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 8731 Services-Commercial Physical & Biological Research